propofol has been researched along with Congenital Rubella Syndrome in 1 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jones, G | 1 |
| Scott, DH | 1 |
1 other study available for propofol and Congenital Rubella Syndrome
| Article | Year |
|---|---|
Anaesthesia for adults with congenital heart disease.
Topics: Adult; Alfentanil; Anesthesia, General; Eye Enucleation; Female; Humans; Propofol; Rubella Syndrome, | 1991 |